Anticancer Activity of Phospholipid-Dexibuprofen Conjugates Loaded in Nanostructured Lipid Carriers
This study describes the synthesis of new conjugates of DXI and phospholipids and their nanotechnological formulations for potential use in cancer therapy.
Authors
- Elena Sánchez‐López (ORCID: https://orcid.org/0000-0003-2571-108X)
- Joanna Wietrzyk (ORCID: https://orcid.org/0000-0003-4980-6606)
- Anna Gliszczyńska (ORCID: https://orcid.org/0000-0002-0218-6369)
- Gabriela Maciejewska (ORCID: https://orcid.org/0009-0004-9804-4032)
- Marta Espina (ORCID: https://orcid.org/0000-0003-1269-3847)
- Vaikunthavasan Thiruchenthooran (ORCID: https://orcid.org/0000-0002-4303-533X)
- Marta Świtalska (ORCID: https://orcid.org/0000-0001-7920-2251)
- Anna Palko-Łabuz (ORCID: https://orcid.org/0000-0002-4246-5717)
- Lorena Bonilla-Vidal
- Eliana B. Souto (ORCID: https://orcid.org/0000-0002-9737-6017)
- María L. García (ORCID: https://orcid.org/0000-0002-4526-3344)
Institutions
- University College Dublin (IE)
- Wrocław University of Science and Technology (PL)
- Medical University of Warsaw (PL)
- Wrocław University of Environmental and Life Sciences (PL)
- Ludwik Hirszfeld Institute of Immunology and Experimental Therapy (PL)
- Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona
- University of Nebraska Medical Center (US)
- Universitat de Barcelona (ES)
- Polish Academy of Sciences (PL)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/ijn.s512505
- Citations
- 2
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 1.19